4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Cardoso, Fátima; Senkus, Elżbieta; Costa, A.; Papadopoulos, Efthymios; Aapro, Matti; André, Fabrice; Harbeck, Nadia; Aguilar Lopez, B.; Barrios, C.H.; Bergh, Jonas; Biganzoli, Laura; Boers-Doets, C.B.; João Cardoso, Maria; Carey, L.A.; Cortés, Javier; Curigliano, Giuseppe; Dièras, Véronique; S. El Saghir, Nagi; Eniu, Alexandru; Fallowfield, Lesley; Francis, P.A.; A. Gelmon, Karen; Johnston, S.; Kaufman, Bella; Koppikar, Smruti; Krop, I.E.; Mayer, Musa; Nakigudde, Gertrude; Offersen, B.V.; Ohno, Shinji; Pagani, Olivia; Paluch–Shimon, Shani; Penault‐Llorca, Frédérique; Prat, Aleix; Rugo, H.S.; W. Sledge, G.; Spence, Danielle; Thomssen, Christoph; Vorobiof, D.A.; Xu, B.; Norton, Larry; Winer, E.P.

doi:10.1093/annonc/mdy192

Public

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Published in Annals of Oncology • May 24, 2018

Authors:

Fátima Cardoso

Elżbieta Senkus

A. Costa

Abstract

Advanced Breast Cancer (ABC) comprises both locally advanced breast cancer (LABC) and metastatic breast cancer (MBC) [1]. Although treatable, MBC remains virtually an incurable disease with a median overall survival (OS) of ∼3years and a 5-year survival of only ∼25% [2, 3]. The MBC Decade Report [2]...

Subject

Medicine

Breast cancer

Oncology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!